Resource Center

When it comes to building the ideal patient cohort, the breadth and variety of demographic and clinical criteria available to select from is critical.etc…

There is growing interest in understanding the patient impact of COVID-19 not just during an acute case, but long afterwards. The mounting evidence of longer-term mental and physical effects suggests a need for better understanding of care requirements beyond the emergency room.

The COVID-19 pandemic has worsened the drug overdose epidemic in the United States. The evidence of the intersection of these public health crises has been recently emphasized in briefs by the CDC and the American Medical Association.etc…

There is growing interest in understanding the patient impact of COVID-19 not just during an acute case, but long afterwards. The mounting evidence of longer-term mental and physical effects suggests a need for better understanding of care requirements beyond the emergency room.

Today, the multiple disparate touch points required for clinical research are burdensome for patients, sites and sponsors.etc…

What is synthetic data and how can it be used to improve patient outcomes and life sciences? In this discussion moderated by Su Huang,etc…

Datavant, a 4 year old startup, has an extremely high bar when we interview candidates. By the numbers, we make an offer to less than 1% of all applicants, yet the criteria we assess for are remarkably straightforward, and preparing for an interview at Datavant should not be difficult if you share our values, are smart, and get things done.

The past year has illustrated the critical role of real-world data and evidence in clinical trials research and healthcare innovation.etc…

3.5 years ago, I founded Datavant to connect the world’s health data to improve patient outcomes. Today, we are announcing the combination of Ciox and Datavant – our biggest step forward to become the neutral, trusted, ubiquitous infrastructure powering the exchange of data across healthcare. This post outlines our vision…